MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Dicerna Pharmaceuticals Company Profile (NASDAQ:DRNA)

Consensus Ratings for Dicerna Pharmaceuticals (NASDAQ:DRNA) (?)
Ratings Breakdown: 1 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $15.00 (304.31% upside)

Analysts' Ratings History for Dicerna Pharmaceuticals (NASDAQ:DRNA)
Show:
DateFirmActionRatingPrice TargetActions
5/10/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Jefferies GroupReiterated RatingBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Stifel NicolausLower Price TargetBuy$20.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/14/2016Chardan CapitalReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha